Deletion analysis of several 17b-estradiol (E 2 )-responsive genes have identified GC-rich sites that are associated with hormone-induced transactivation in MCF-7 breast cancer cells. However, the role of individual specificity proteins (Sps) in mediating hormone-induced gene expression has not been unequivocally determined. In transient transfection studies using E 2 -responsive GC-rich promoters from the E 2 F1, carbamoylphosphate synthetase/aspartate transcarbamylase/dihydroorotase (CAD), and retinoic acid receptor a (RARa) genes, RNA interference using small inhibitory RNAs for Sp1 (iSp1), Sp3 (iSp3), and Sp4 (iSp4) decreased both basal and E 2 -induced transactivation. The contributions of individual Sp proteins to basal and E 2 -induced activity were promoter dependent. iSp1, iSp3, and iSp4 also significantly inhibited hormonal induction of E 2 F1, CAD, and RARa mRNA levels; however, the enhanced inhibitory effects of the latter two small inhibitory RNAs suggest that Sp3 and Sp4 play a major role in estrogen receptor a/Sp-mediated gene expression in MCF-7 cells.
Introduction
The estrogen receptor (ER) is a member of the nuclear receptor superfamily of transcription factors and is required for mediating 17b-estradiol (E 2 )-induced responses in multiple tissues and organs (Chow et al. 1992 , Turner et al. 1994 , Farhat et al. 1996 , Clark 1998 . Two major ER subtypes (ERa and ERb) and multiple splice variants have been identified and these various forms exhibit both overlapping and different activities (Hall et al. 2001 , Olefsky 2001 , Nilsson & Gustafsson 2002 , Matthews & Gustafsson 2003 . ERa and ERb exhibit the typical domain structures of nuclear receptors, and similarities in their DNA binding (C) and ligand binding (EF) domains are correlated with comparable mechanisms of DNA binding and similar but not identical interactions with various estrogenic ligands (Hall et al. 2001 , Olefsky 2001 , Nilsson & Gustafsson 2002 , Matthews & Gustafsson 2003 . The N-terminal regions (AB) of human ERa and ERb exhibit only 17% amino acid homology and this variability may account for some of the differences between the ER subtypes such as those observed in the murine uterus where ERb tends to inhibit ERa-dependent uterotrophic responses (Krege et al. 1998 , Weihua et al. 2000 .
The classical ER mechanism of action involves ligandinduced formation of an ER homodimer which interacts with estrogen responsive elements (EREs; Klein-Hitpass et al. 1986 , Cowley et al. 1997 , Hyder et al. 1999 in target gene promoters and recruits cofactors necessary for transactivation. There is an increasing evidence that the classical genomic ER-ERE complex formation is only one of several genomic and non-genomic pathways of estrogen action (Blobel & Orkin 1996 , Delfino & Walker 1999 , Kelly & Wagner 1999 , Kushner et al. 2000 , Watson et al. 2002 , Razandi et al. 2004 , Safe & Kim 2004 , Levin 2005 . Genomic ER associates with other transcription factors such as the activating protein-1 (AP-1) complex, nuclear factor kappa B (NFkB), and specificity proteins (Sps) to modulate ligand-dependent gene expression. For example, studies in this laboratory and others have demonstrated that deletion and mutational analysis of promoters derived from several E 2 -responsive genes contain GC-rich motifs that bind Sp proteins (Safe & Kim 2004) . Some of the genes that fall into this category are important for cell proliferation, angiogenesis, and nucleotide metabolism and include E 2 F1, retinoic acid receptor a (RARa), carbamoylphosphate synthetase/ aspartate transcarbamylase/dihydroorotase (CAD), bcl-2, DNA polymerase a, vascular endothelial growth factor (VEGF), VEGFR receptor 2 (VEGFR2), progesterone receptor, creatine kinase B, thymidylate synthase, insulinlike growth factor binding protein 4, epidermal growth factor receptor, receptor for advanced glycation end products, low density lipoprotein receptor, vitamin D receptor, pS2, LRP16, metastasis associated protein 3, and SK3 (Porter et al. 1996 , Duan et al. 1998 , Sun et al. 1998 , 2005 , Qin et al. 1999 , Xie et al. 1999 , 2000 , Byrne et al. 2000 , Salvatori et al. 2000 , Saville et al. 2000 , Stoner et al. 2000 , Tanaka et al. 2000 , Castro-Rivera et al. 2001 , Li et al. 2001 , Bruning et al. 2003 , Jacobson et al. 2003 , Khan et al. 2003 , Ngwenya & Safe 2003 , Schultz et al. 2003 , 2005 , Fujita et al. 2004 , Bardin et al. 2005 , Zhao et al. 2005 , Higgins et al. 2006b ). In addition, RNA interference studies with a small inhibitory RNA (siRNA) for Sp1 (iSp1) show that after transfection with iSp1, there was a significant decrease in hormone-induced G 0 /G 1 to S-phase progression, suggesting that ERa/Sp1 plays an important role in this process (Abdelrahim et al. 2002) .
MCF-7 cells express multiple Sp proteins including Sp1, Sp3, and Sp4, and the role of these individual proteins in mediating E 2 -induced transactivation has not been determined. Using the E 2 F1 gene as a model, we now show that hormonal activation of a GC-rich E 2 F1 promoter construct is inhibited in cells cotransfected siRNAs for Sp1, Sp3 (iSp3), and Sp4 (iSp4), and using this approach, it was shown that these Sp proteins are also important for hormone-induced expression of E 2 F1 mRNA and protein. Similar results were observed for two other E 2 -responsive genes, CAD and RARa, demonstrating that all three Sp proteins and particularly Sp3 and Sp4 are important for ERa/Sp-mediated gene expression in MCF-7 cells.
Materials and methods
Cells, chemicals, biochemicals, and plasmids MCF-7 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and were cultured in DME/F12 (Sigma Chemical Co.) media supplemented with 5% fetal bovine serum (FBS; JRH Biosciences, Lenaxa, KS, USA; or Atlanta Biologicals Inc., Norcross, GA, USA), 1 . 5 g/l sodium bicarbonate, and 10 ml/l antibiotic-antimycotic solution (Sigma). Cells were maintained in incubators at 37 8C under humidified 5% CO 2 : 95% air. Dimethyl sulfoxide (Me 2 SO), PBS, and E 2 were purchased from Sigma. Reporter lysis buffer and luciferase assay reagent were purchased from Promega Corp. and/or Boehringer Mannheim. b-Galactosidase activity was measured using Tropix Galacto-Light Plus assay system (Tropix, Bedford, MA, USA). Instant Imager and Lumicount micro-well plate reader were purchased from Packard Instrument Co. (Downers Grove, IL, USA). b-Actin antibody was obtained from Sigma and all other antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Human ERa expression plasmid was originally provided by Dr Ming-Jer Tsai (Baylor College of Medicine, Houston, TX, USA) and was recloned into pcDNA3 in this laboratory. Promoter luciferase construct pRARa2 (K79/K49) was made by inserting the oligonucleotide spanning K79 to K49 of the human RARa1 promoter into the pGL2 basic luciferase reporter plasmid (Promega Corp). CAD promoter luciferase construct pCAD2 (K90/C25) was kindly provided by Dr Peggy Farnham (University of Wisconsin, Madison, WI, USA). E 2 F1 promoter luciferase construct pE 2 F1h was made in this laboratory as described . Plasmid pSp1 3 containing three consensus Sp1 binding sites linked to a luciferase reporter gene was cloned into pXP2 plasmid in this laboratory.
Transient transfection assays of small inhibitory RNA Validated, non-targeting small inhibitory RNA (siRNA; Silencer Negative Control siRNA; iNS1) was purchased from Ambion (Austin, TX, USA) and siRNAs for Sp1, Sp3, and Sp4 were purchased from Dharmacon Research (Lafayette, CO, USA). MCF-7 cells were seeded in DME/F12 medium supplemented with 2 . 5% charcoalstripped serum overnight in 12-well plates. After 16-20 h, siRNA duplexes were transfected using Lipofectamine 2000 Reagent (Invitrogen Life Technologies). After 24 h, reporter plasmids (200 ng) were cotransfected with ERa expression plasmid (150 ng) and 50 ng pCDNA3.1-His-LacZ using GeneJuice (Novagen, EMD Biosciences Inc., Madison, WI, USA) according to the manufacturer's protocol. Cells were then treated for 36 h with Me 2 SO or E 2 and harvested in 100 ml of cell lysis buffer (Promega Corp). Luciferase activities in the various treatment groups were performed on 20 ml of cell extract using the luciferase assay system (Promega Corp.) in a luminometer (Packard Instrument Co., Meriden, CT, USA) and results were normalized to b-galactosidase enzyme activity, which was carried out on 20 ml of cell extract. Sequences of siRNA oligonucleotides for Sp1, Sp3, and Sp4 are summarized below. Sp1: 5 0 -AUC ACU CCA UGG AUG AAA UGA dTdT-3 0 Sp3: 5 0 -GCG GCA GGU GGA GCC UUC ACU dTdT-3 0 Sp4: 5 0 -GCA GUG ACA CAU UAG UGA GC dT dT-3 0
Preparation of whole cell extracts and western blot analysis
MCF-7 cells were seeded into six-well plates in DME/F12 medium supplemented with 2 . 5% charcoal-stripped serum. The next day, cells were transfected with siRNAs using Lipofectamine 2000 reagent according to the manufacturer's protocol. After 55-60 h, cells were dosed with Me 2 SO and E 2 for 18 h and then harvested with ice-cold lysis buffer (50 mM HEPES (pH 7 . 5), 500 mM NaCl, 10% (v/v) glycerol, 1% Triton X-100, 1 . 5 mM MgCl 2 , and 1 mM EGTA) and supplemented with protease inhibitor cocktail (Sigma). Equal amounts of protein from each treatment group were boiled in 1! sample buffer (50 mM Tris-HCl, 2% SDS, 0 . 1% bromphenol blue, S KHAN and others . Hormonal activation of ERa/Sp in MCF-7 cells and 175 mM b-mercaptoethenol) for 5 min and separated on 7 . 5 or 10% gel, and then transferred to polyvinylidene difluoride membrane (Bio-Rad) overnight at 30 V. Membranes were blocked in Blotto (5% milk, Tris-buffered saline (10 mM Tris-HCl (pH 8 . 0) and 150 mM NaCl), and 0 . 05% Tween 20) for 30 min and probed with primary antibodies for 2-4 h. Membranes were washed for 30 min in 1! TBS-Tween, probed with peroxidase-conjugated secondary antibody for 1-2 h, and then washed in 1! TBS-Tween for 30 min. Ten millilitres of HRP substrate (Dupont-NEN, Boston, MA, USA) were added and incubated for 1 min and visualized by autoradiography. Protein band intensities were scanned on a JX-330 scanner (SHARP Corp., Mahwah, NJ, USA) using Adobe Photoshop 3.0 (Adobe Systems Inc., San Jose, CA, USA).
Immunohistochemistry
For ERa-Sp1 colocalization experiments, MCF-7 cells were seeded onto two-well glass chamber slides (Nalge Nunc International, Naperville, IL, USA) at 100 000 cells per well in Dulbecco's modified Eagle's medium (DMEM)/F12 medium supplemented with 5% charcoal stripped FBS, incubated in a 37 8C incubator with 5% CO 2 for 24 h, and treated with Me 2 SO vehicle or 10 nM E 2 for 1 h. Slides were then washed with PBS, fixed with K20 8C methanol, air dried, and washed with PBS C0 . 3% Tween 20 (PBS/Tween). Slides were blocked for 1 h with 5% donkey serum in antibody dilution buffer (1% BSA in PBS/Tween), washed with PBS/Tween briefly, incubated with anti-Sp1 PEP-2 (goat) antibody (Santa Cruz) at 1:100 dilution (goat serum for controls) in antibody dilution buffer at 4 8C for 12 h. Slides were washed with PBS/Tween (3!10 min), incubated with donkey antigoat immunoglobulin G (IgG) fluorescein isothiocyanate (FITC) (Santa Cruz) at 1:200 dilution in antibody dilution buffer for 1 h and washed with PBS/Tween (3! 10 min). Slides were subsequently blocked with 5% donkey serum in antibody dilution buffer for 1 h, washed with PBS/Tween briefly, incubated with anti-ERa H-184 antibody (Santa Cruz) at 1:100 dilution in antibody dilution buffer at 4 8C for 12 h (rabbit serum for controls), washed with PBS/Tween (3!10 min), incubated with donkey anti-rabbit IgG Alexa Fluor 594 (Molecular Probes, Eugene, OR, USA) at 1:500 dilution in antibody dilution buffer for 1 h, and washed with PBS/Tween (3!10 min). Slides were finally washed in deionized water, and cover glass mounted using Prolong Gold antifade reagent with DAPI (Molecular Probes). Immunofluorescence images of Sp1 and ERa were examined using a Zeiss Axioplan2 microscope (Carl Zeiss, Thornwood, NY, USA) fitted with an Axiocam highresolution digital camera. Digital images were captured using Axiovision 4.1 software (Carl Zeiss).
For ERa-Sp4 colocalization experiments, COS-7 cells were seeded as described above, transfected with 250 ng of ERa and 250 ng of Sp4 expression plasmid using GeneJuice transfection reagent (Novagen), incubated at 37 8C with 5% CO 2 for 24 h, and then treated with Me 2 SO vehicle or 10 nM E 2 for 1 h, and immunostaining experiments were carried out as described above using ERa D-12 (Santa Cruz) paired with donkey anti-mouse Alexa Fluor 488 (Molecular Probes) and Sp4 V-20 (Santa Cruz) paired with donkey anti-rabbit IgG Alexa Fluor 594 (Molecular Probes) antibodies.
Real-time PCR
Cells were seeded into six-well plates in DME/F12 medium supplemented with 2 . 5% charcoal-stripped serum overnight. The next day cells were transfected with siRNAs using Lipofectamine 2000 Reagent and, after 55-60 h, cells were treated with Me 2 SO or E 2 for 6 or 12 h. RNA was extracted using Qiagen RNeasy minikit (Qiagen) following the manufacturer's protocol and was reverse transcribed for cDNA synthesis using Superscript II reverse transcriptase (Invitrogen) according to the manufacturer's protocol. The cDNA reaction mixture was then used to carry out PCR using SYBR Green PCR Master Mix from PE Applied Biosystems (Warrington, UK) on an ABI Prism 7700 Sequence Detection System (PE Applied Biosystems). The relative quantitation of samples was carried out using comparative C T method and TATA binding protein (TBP) was used for normalization. Quantitect primer assays (Qiagen) for Sp1, Sp3, Sp4, E 2 F1, and CAD were used to perform PCR, whereas primers for RARa and TBP were purchased from Integrated DNA technologies (Coralville, IA, USA) and are as follows:
Chromatin immunoprecipitation (ChIP) assay MCF-7 cells (1!10 7 ) were treated with Me 2 SO (time 0) or E 2 (10 nM) for different times. Cells were then fixed with 1 . 5% formaldehyde, and the cross-linking reaction was stopped by addition of 0 . 125 M glycine. Cells were scraped, pelleted, and hypotonically lysed, and nuclei were collected. Nuclei were then sonicated to the desired chromatin length (w500 bp). The chromatin was precleared by addition of protein A/G-conjugated beads (Pierce, Rockford, IL, USA). The precleared chromatin supernatants were immunoprecipitated with antibodies specific to IgG, ERa, Sp1, Sp3, and Sp4 (Santa Cruz Biotechnology) at 4 8C overnight. The protein-antibody complexes were collected by addition of protein A/G-conjugated beads for 1 h, and the beads were extensively washed. The protein-DNA crosslinks were eluted and reversed. DNA was purified by Qiaquick Spin Columns (Qiagen) followed by PCR amplification. The pS2 primers are: 5 0 -CTA GAC GGA ATG GGC TTC AT-3 0 (forward) and 5 0 -ATG GGA GTC TCC TCC AAC CT-3 0 (reverse), which amplify a 209-bp region of the human pS2 promoter containing an estrogen response element (ERE). The CAD primers are: 5 0 -CTT GGG GTG GGA GGG ACT-3 0 (forward) and 5 0 -GCG GCA GCA GCA GAG ACT-3 0 (reverse), which amplify a 158-bp GC-rich region of the human CAD promoter. The RARa primers are: 5 0 -GCC CTT CCC GAG GTC TAT TA-3 0 (forward) and 5 0 -GAG GGT ACG GAG CAG AGG TA-3 0 (reverse), which amplify a 138-bp GC-rich region of the human RARa promoter. The E 2 F1 primers are: 5 0 -CTG gta cca tcc gga caa ag-3 0 (forward) and 5 0 -TTT TTG CCG CGA AAG AGC-3 0 (reverse), which amplify a 198-bp region of the human E 2 F1 promoter containing GC-rich Effects of (D) iSp1, (E) iSp3, and (F) iSp4 on protein expression. MCF-7 cells were transfected with siRNAs as described above, treated with Me 2 SO (D) or 10 nM E 2 (E) and whole cell lysates were analyzed by western blot analysis as described in Materials and methods.
Sp-binding sites. PCR products were resolved on a 2% agarose gel in the presence of 1:10 000 SYBR gold (Molecular Probes).
Statistical analysis
Experiments were repeated two or more times, and data are expressed as meanGS.E.M. for at least three replicates for each treatment group. Statistical differences between treatment groups were determined using Super ANOVA and Scheffé's test. Treatments were considered significantly different from controls if P!0 . 05.
Results

Role of Sp proteins of hormonal activation of pSp1 3
Analysis of several gene promoters from E 2 -responsive genes have identified GC-rich motifs that are required 
Role of Sp proteins in hormonal activation of pSp1 3 . MCF-7 cells were cotransfected with pSp1 3 and iNS1, iSp1, iSp3, iSp4, or their combinations, treated with Me 2 SO (D) or 10 nM E 2 (E), and (A) luciferase activity or (B) fold induction of luciferase activity by E 2 was determined as described in the Materials and methods. Results are expressed as meansGS.E.M. for at least three replicate determinations for each treatment group, and significantly (P!0 . 05) decreased basal or E 2 -induced activity (compared with iNS1) is indicated by a double asterisk. Significant (P!0 . 05) induction by E 2 compared with Me 2 SO is also indicated (*). for hormone-induced transactivation in breast cancer and other cell lines (Porter et al. 1996 , Duan et al. 1998 , Sun et al. 1998 , 2005 , Qin et al. 1999 , Xie et al. 1999 , 2000 , Byrne et al. 2000 , Salvatori et al. 2000 , Saville et al. 2000 , Stoner et al. 2000 , Tanaka et al. 2000 , Castro-Rivera et al. 2001 , Li et al. 2001 , Bruning et al. 2003 , Jacobson et al. 2003 , Khan et al. 2003 , Ngwenya & Safe 2003 , Schultz et al. 2003 , 2005 , Fujita et al. 2004 , Bardin et al. 2005 , Zhao et al. 2005 , Higgins et al. 2006b ). In this study, we have also used RNA interference and small inhibitory RNAs (siRNAs) for Sp1 (iSp1), Sp3 (iSp3), and Sp4 (iSp4) to investigate the role of individual Sp proteins in ERa/Sp-mediated transactivation in MCF-7 cells. Previous studies in cancer cell lines have demonstrated the specificity and effectiveness of iSp1, iSp3, and iSp4 in Sp protein knockdown (Abdelrahim et al. 2002 , Higgins et al. 2006a , and results in Fig. 1A -C illustrate that transfected iSp1, iSp3, and iSp4 significantly decreased Sp1, Sp3, and Sp4 mRNA levels in whole cell extracts from MCF-7 cells. In parallel studies, transfected iSp1, iSp3, and iSp4 also decreased Sp1, Sp3, and Sp4 protein expression ( Fig. 1D-F) in MCF-7 cells. The pSp1 3 construct has been extensively used as a model to investigate the mechanisms of ERa/Spmediated transactivation (Saville et al. 2000 , Kim et al. 2003 , 2005 . This construct contains three tandem consensus GC-rich binding sites linked to a minimal TATA-luciferase and is E 2 responsive only after cotransfection with ERa and this is due, in part, to overexpression of pSp1 3 in transfected cells and limiting levels of ERa. This system has been ideal for studying hormone activation of pSp1 3 in ER-positive or ER-negative cell lines thereby determining the contributions of cell context on the induction response (Saville et al. 2000 , Kim et al. 2003 , 2005 . Results illustrated in Fig. 2A show that E 2 induces transactivation in MCF-7 cells transfected with pSp1 3 and non-specific RNA (iNS1) and similar results were obtained in the presence or absence of transfected iNS1 oligonucleotide (data not shown). The results show that all three siRNAs or their combinations significantly decreased basal luciferase activity, and iSp1 and iSp4 were more effective than iSp3. The fold induction of luciferase by E 2 compared with solvent (Me 2 SO) control shows that the effectiveness of the siRNAs for decreasing fold induction was iSp1OiSp4OiSp3 ( Fig. 2B ) with only minimal changes in fold induction observed for iSp4 and iSp3. The apparent lack of effectiveness of iSp4 and iSp3 for inhibiting fold induction of luciferase activity when compared with iSp1 was due, in part, to their differential inhibitory effects on basal luciferase activity. In cells transfected with iSps in combination, the maximal inhibition of fold induction was observed in cells transfected with iSp1/iSp3 and iSp1/iSp4, whereas minimal changes were observed in cells transfected with iSp3/iSp4. However, these data suggest that for the pSp1 3 construct containing three consensus GC-rich sites, Sp1 plays the most important role in E 2 -dependent activation of ERa/Sp. ERa/Sp-mediated activation of E 2 F1 E 2 induces E 2 F1 gene expression in MCF-7 cells , Ngwenya & Safe 2003 , and promoter analysis has identified critical GC-rich sites at between K169 and K111 in the proximal region of the E 2 F1 promoter. Figure 3A illustrates luciferase activity in MCF-7 cells transfected with pE 2 F1 (K169/K54) and various iSps or their combinations. The results show that individual siRNAs for Sp1, Sp3, and Sp4 decreased luciferase by 70-90% with iSp3 as the most effective siRNA. These results indicate that Sp proteins play the major role in regulating basal luciferase activity in MCF-7 cells transfected with pE 2 F1 (K169/K54). Moreover, the effectiveness of iSp1, iSp3, and iSp4 in decreasing activity suggests that the loss of any single Sp protein was important for transcription, indicating cooperative interactions among these transcription factors for regulating luciferase activity. The effects of individual and combined Sp protein knockdown in MCF-7 cells transfected with pE 2 F1 (K169/K54) and treated with Me 2 SO or E 2 were also determined, and the effects on fold induction by E 2 are illustrated in Fig. 3B . With the exception of the results observed for iSp3, the fold induction by E 2 was decreased 50-65% by iSp1, iSp4, and their combinations (including iSp3CiSp1 and iSp3CiSp4). iSp3 only slightly decreased the fold induction by E 2 and was less effective than either iSp1 or iSp4. These results were similar to those observed for the effects of iSps on hormone inducibility in MCF-7 cells transfected with pSp1 3 (Fig. 2A) .
The effects of siRNAs for Sp proteins on induction of E 2 F1 mRNA levels in MCF-7 cells were also investigated. Cells were transfected with iNS1 (non-specific RNA), iSp1, iSp3 or iSp4 for 55-60 h, then treated with Me 2 SO or 10 nM E 2 for an additional 12 h and mRNA levels were determined in whole cell extracts by real-time PCR. Previous studies show that within this time period, there is a maximal decrease of Sp proteins using these siRNAs (Abdelrahim et al. 2002 , Higgins et al. 2006a . Basal E 2 F1 mRNA levels were significantly decreased by transfecting iSp1, iSp3, and iSp4 by 40, 86, and 77% respectively, demonstrating the role of Sp proteins in mediating E 2 F1 mRNA expression. E 2 induced an approximately threefold increase in E 2 F1 mRNA expression and in cells transfected with iSp1, iSp3, and iSp4, there were significant decreases in hormoneinduced E 2 F1 mRNA levels and cells transfected with iSp4 gave the lowest inducibility. However, the results suggest that all three Sp proteins are involved in ERa/ Sp-dependent activation of E 2 F1. iSp3 was more effective in decreasing induction of E 2 F1 mRNA by E 2 (Fig. 3C replicate determinations for each treatment group, and significantly (P!0 . 05) decreased basal or hormone-induced activity (compared with iNS1) is indicated (**). The effects of ER expression plasmid on hormone inducibility is also indicated. (C) Role of Sp proteins in hormonal activation of CAD mRNA. MCF-7 cells were transfected with iNS, iSp1, iSp3, or iSp4, treated with Me 2 SO (D) or 10 nM E 2 (E) for 6 h, and mRNA levels determined as described in the Materials and methods. CAD mRNA levels (normalized to TBP mRNA) are meansGS.E.M. for at least three determinations and significantly (P!0 . 05) decreased hormone-induced CAD mRNA is indicated (**).
Significant induction by E 2 compared with ME 2 SO is indicated (*).
S KHAN and others . Hormonal activation of ERa/Sp in MCF-7 cells than decreasing induction of luciferase activity by E 2 in cells transfected with pE 2 F1h (Fig. 3B ). This suggests that other regulatory regions of E 2 F1 that are affected by Sp3 are important for induction of E 2 F1 mRNA levels by E 2 . We also observed in a separate experiment that induction of E 2 F1 protein by E 2 and basal E 2 F1 protein expression were also decreased in MCF-7 cells transfected with iSp1, iSp3, and iSp4 (Fig. 3D) . These results demonstrate the hormone inducibility of E 2 F1 is dependent on Sp transcription factors. Thus, although Sp3 plays a minimal role in hormone-induced activation of pE 2 F1 (K169/K54), this transcription factor is important for mediating hormone-dependent induction of E 2 F1 mRNA and protein.
ERa/Sp-mediated activation of CAD and RARa
The K90 to C25 region of the CAD gene promoter is also E 2 responsive in transfection assays, and deletion and mutation analyses have identified three proximal GC-rich sites which are required for hormone responsiveness (Khan et al. 2003) . Results in Fig. 4A show that in MCF-7 cells transfected with pCAD (K90/C25), cotransfection with iSp1, iSp3, iSp4, or their combinations significantly decreased activity (O50%); however, the magnitude of the decreased activity was significantly less than observed for pE 2 F1 (K169/K54; Fig. 3A ). Since the magnitude of the decreased response was similar after transfection with iSp1, iSp3, or iSp4, it is likely that all three transcription factors are required for basal activity. In MCF-7 cells transfected with pCAD (K90/C25) plus iNS1 and treated with Me 2 SO or E 2 , cotransfection with iSp1, iSp3, iSp4, or their combinations significantly decreased hormone-induced transactivation (Fig. 4B ). Fold induction was decreased only slightly more effectively in cells transfected with iSp1 and iSp4 when compared with iSp3; however, all three Sp transcription factors were important for hormone responsiveness and combinations of iSps inhibited hormone inducibility more than individual siRNAs. Similar results were observed for induction of CAD mRNA levels by E 2 (Fig. 4C) where the induction response was significantly decreased in MCF-7 cells transfected with iSp1, iSp3, and iSp4. In contrast, iSps had only a minimal effect of CAD mRNA levels (data not shown). We also investigated the role of Sp proteins in hormonal activation of RARa since previous studies have identified proximal GC-rich motifs at K68 to K62 and K59 to K52 required for hormonal activation of promoter constructs (Sun et al. 1998) . In contrast to the pCAD (K90/C25) and pE 2 F1 (K169/K54) constructs, basal luciferase activity was not decreased in MCF-7 cells transfected with pRARa (K79/K49) and iSp1 or iSp4 but was significantly decreased only after cotransfection with iSp3 ( Fig. 5A) . Cotransfection with iSp combinations (except iSp1CiSp3) decreased activity; however, it was evident that despite the presence of GC-rich motifs in pRARa (K79/K49), Sp proteins were not the predominant transcription factors required for basal activity. In contrast, fold inducibility of luciferase activity in MCF-7 cells treated with Me 2 SO or 10 nM E 2 and transfected with pRARa (K79/K49) was primarily decreased in cells transfected with iSp1 and iSp4 but not iSp3 (Fig. 5B ). Since both iSp1 and iSp4 significantly decreased hormone responsiveness, any combination of these siRNAs inhibited E 2 -induced transactivation. Thus, hormone-dependent activation of pRARa (K79/K49) was primarily dependent on ERa/Sp1 and ERa/Sp4, and this was similar to results obtained with pSp1 3 (Fig. 2B ) and pE 2 F1 (K169/K54; Fig. 3B ). Basal expression of RARa mRNA was only minimally affected by iSps (data not shown); however, induction of RARa mRNA levels by E 2 was decreased after cotransfection with iSp1, iSp3, and iSp4 with iSp3 being the most effective siRNA (Fig. 5C ). iSp3 completely abrogated induction of RARa by E 2 , whereas in transfection studies with pRARa2, which contains a K79 to K49 RARa promoter insert, iSp3 did not significantly decrease hormone responsiveness (Fig. 5B) . These results suggest that GC-rich sites in addition to those at K79 to K49 may be important for ERa/Sp-mediated induction of RARa mRNA by E 2 .
Colocalization of ERa with Sp1 and Sp4
Previous studies showed that ERa interacts with Sp1 and Sp3 (Porter et al. 1996 , Saville et al. 2000 , Stoner et al. 2000 ; however, the results of RNA interference assays now demonstrate that, in MCF-7 cells, Sp4 plays an important role in E 2 -dependent activation of ERa/Sp. Therefore, we have investigated colocalization of ERa and Sp1 in MCF-7 cells, which exhibit endogenous expression of both proteins (Fig. 6A ). ERa and Sp1 proteins alone exhibit nuclear staining and the colocalized proteins exhibit a punctate staining pattern, and these results complement previous studies showing direct interactions of both proteins (Porter et al. 1997) . Colocalization experiments with ERa and Sp4 were examined in COS-7 cells transfected with ERa and Sp4 expression plasmids (Fig. 6B) . Immunostaining of endogenous Sp4 in MCF-7 cells was weak due to the relative insensitivity of the commercially available antibodies; however, in transfected COS-7 cells, Sp4 staining is observed and is more intense in the central part of the nucleus. ERa alone is uniformally observed in the nucleus and, after treatment with E 2 , a more punctate staining is observed and the colocalized ERa/Sp4 also exhibited punctate staining. Several attempts to investigate colocalization of ERa and Sp3 were unsuccessful, due to the failure of available Sp3 antibodies to detect Sp3 by this method. However, these results demonstrate that ERa colocalizes with Sp1 and Sp4 and these transcription factors play an important role in ERa/Sp-mediated expression of E 2 F1, CAD, and RARa ). MCF-7 cells were transfected with pRARa (K79/K49) and iNS1, iSp1, iSp3, iSp4, or their combinations, and luciferase activity determined as described in the Materials and methods. Hormonal activation of pRARa requires cotransfection with ERa. Results are expressed as meansGS.E.M. for three replicate determinations for each treatment group, and significantly (P!0 . 05) decreased basal or hormone-induced activity (compared with iNS1) is indicated (**). (C) Role of Sp proteins in hormonal activation of RARa mRNA. MCF-7 cells were transfected with iNS, iSp1, iSp3, or iSp4, treated with Me 2 SO (D) or 10 nM E 2 (E) for 12 h, and mRNA levels determined as described in the Materials and methods. RARa mRNA levels (normalized to TBP mRNA) are expressed as meansGS.E.M. for at least three determinations and significantly (P!0 . 05) decreased induction (fold) of RARa mRNA by E 2 is indicated (**). Significant induction by E 2 compared with ME 2 SO is indicated (*). S KHAN and others . Hormonal activation of ERa/Sp in MCF-7 cells in MCF-7 cells. However, the effects of E 2 on colocalization are minimal, suggesting interactions of ERa with Sp proteins in the presence or absence of hormone, and this is consistent with previous ChIP assays (Higgins et al. 2006a ) and the reported coimmunoprecipitation of ERa and Sp1 (Ghormone; Saville et al. 2000) .
Interactions of ERa and Sp proteins with the pS2, E 2 F1, CAD, and RARa gene promoters
Previous studies show that the E 2 -responsive region of the pS2 gene promoter contains GC-rich motifs and ChIP analysis of the pS2 promoter (Fig. 7A) shows constitutive binding of Sp1, Sp3, and Sp4. The band intensities exhibit minimal changes after treatment with 10 nM E 2 for up to 2 h. However, as previously reported (Shao et al. 2002 , Metivier et al. 2003 , Acevedo et al. 2004 , Krieg et al. 2004 , Sun et al. 2005 , treatment of MCF-7 cells recruits ERa to the pS2 promoter, and this is consistent with interactions with the ERE motif at K405 to K393. Results in Fig. 7B -D summarize ChIP assays, which examine basal and hormone-induced interactions of ERa, Sp1, Sp3, and Sp4 with the GC-rich regions of the RARa, E 2 F1, and CAD gene promoters respectively. Sp1, Sp3, and Sp4 are constitutively bound to all three promoters and treatment with E 2 does not increase or decrease Sp interactions with these promoters. Moreover, similar results were also observed for ERa which was bound to the GC-rich RARa, E 2 F1, and CAD gene promoters in the presence or absence of hormone treatment. Since Sp1, Sp3, and Sp4 Figure 6 Colocalization of ERa with Sp1 and Sp4 in (A) MCF-7 and (B) COS-7 cells. MCF-7 and COS-7 cells were seeded in two-well chamber slides. The latter cells were transfected with ERa and Sp4 expression plasmids. Both cell lines were treated with Me 2 SO or 10 nM E 2 for 1 h, and cells were immunostained as described in the Materials and methods. are important for basal expression of the genes examined in this study, it is not surprising that these proteins are associated with these GC-rich promoters. These results are consistent with the known ligand-independent interactions of ERa with Sp proteins (Porter et al. 1997 , Saville et al. 2000 , Stoner et al. 2000 , and the colocalization of ERa with Sp1 and Sp4 in Me 2 SO (and E 2 )-treated cells (Fig. 6) . Moreover, we have recently reported similar ERa and Sp interactions with the VEGFR2 promoter in ZR-75 cells using a ChIP assay (Higgins et al. 2006b ). Our results demonstrate for the first time that hormonal activation of genes containing E 2responsive GC-rich promoters in MCF-7 cells requires ERa interactions with Sp1, Sp3, and Sp4. Figure 7 ChIP assay of ERa and Sp protein interactions with E 2 -responsive gene promoters. MCF-7 cells were treated with Me 2 SO (D) or 10 nM E 2 for different time points, and the interaction of ERa and Sp proteins to the (A) pS2, (B) RARa, (C) E 2 F1, and (D) CAD gene promoters was determined in a ChIP assay as described in the Materials and methods. Similar results were obtained in duplicate experiments. We also observed specific binding of transcription factor IIB to the glyceraldehyde 3-phosphate dehydrogenase promoter and not to exon 1 of the CNAP1 gene (data not shown). This serves as an additional positive control for the ChIP assay (Higgins et al. 2006b ).
Discussion
The mechanism of ligand-dependent activation of nuclear receptors involves a simple concept in which receptor ligands induce formation of a transcriptionally active receptor complex bound to a cognate response element in the target gene promoter. However, transactivation mediated by nuclear receptors such as steroid hormone receptors is highly complicated and is dependent on ligand structure, hormone receptor subtype, tissue-specific expression of coactivators, other nuclear cofactors, and promoter context (Katzenellenbogen et al. 1996 , Lemon & Freedman 1999 , Klinge 2000 , Rosenfeld & Glass 2001 , Smith & O'Malley 2004 . For example, although E 2 activates hormone-responsive gene expression in multiple tissues, other ER agonists such as the antiestrogen tamoxifen exhibit tissue-specific ER agonist and antagonist activities (Jordan 2003a,b) . Differences between the activities of E 2 and tamoxifen and other antiestrogens are due, in part, to their ligandinduced conformational changes in the ER and their subsequent differences in binding affinities for specific nuclear coactivators (Schwabe et al. 1993 , Brzozowski et al. 1997 , Shiau et al. 1998 , Pike et al. 1999 , Jordan 2003a . ER/Sp1-dependent transactivation is also complex and dependent on multiple variables. For example, E 2 activates ERa/Sp but not ERb/Sp in several different cell lines and in HeLa cells, E 2 decreases ERb/Sp1dependent transactivation and this may be a pathway for decreased gene expression by hormones (Saville et al. 2000) . In addition, there is also evidence that activation of ERa/Sp1 involves multiple domains of ERa and domain requirements are also dependent on the structure of the ER agonist (Saville et al. 2000 , Kim et al. 2003 . Previous studies have identified multiple gene promoters activated by ERa/Sp and Sp1 knockdown by RNA interference inhibits hormone-induced G 0 /G 1 to S-phase progression in MCF-7 cells (Abdelrahim et al. 2002) . However, the role of individual Sp1, Sp3, and Sp4 proteins in mediating ERa/ Sp-induced gene expression in MCF-7 cells has not been determined. In this study, we have used RNA interference to investigate the effects of Sp protein knockdown (individual and combined) on induction of E 2 F1, RARa, and CAD gene expression by E 2 since all three genes contain GC-rich promoters that are E 2--responsive in transfection studies , Khan et al. 2003 , Ngwenya & Safe 2003 .
The siRNAs for Sp proteins are highly specific and have been used in several studies (Abdelrahim et al. 2002 , Higgins et al. 2006a , and they efficiently decrease expression of both Sp1, Sp3, and Sp4 mRNA and protein (Fig. 1) . The effects of iSps on basal luciferase activity in MCF-7 cells transfected with pSp1 3 , pE 2 F1 (K169/K54), pCAD (K90/C25), and pRARa (K79/K49) demonstrated that despite common GC-rich sites in all three promoters, decreased Sp protein expression differentially affected activity. Luciferase activity in cells transfected with pE 2 F1 (K169/K54) was decreased w70-90% after cotransfection with iSp1, iSp3, and iSp4, whereas in cells transfected with pRARa (K79/K49), only iSp3 decreased activity and iSp1 actually increased activity. Although basal activity of the four promoters were differentially affected by Sp protein knockdown, E 2 -induced transactivation in cells transfected with these constructs, and fold induction was decreased in cells transfected with iSp1 or Sp4 (and their combinations), whereas iSp3 was the least effective or ineffective at decreasing fold induction. However, this may be, in part, due to the effects of iSp3 on decreasing basal activity in cells transfected with iSp1 3 , pRARa (K79/K49), and pE 2 F1 (K169/K54). All three iSps induced a comparable decrease in basal activity in MCF-7 cells transfected with pCAD (K90/C25) and iSp3 also decreased hormone-induced activity with this construct. Transfected iSps significantly decreased induction of E 2 F1, RARa, and CAD mRNA levels by E 2 in MCF-7 cells (Figs 3-5), and the order of effectiveness was iSp4RiSp3OiSp1. Knockdown of Sp3 resulted in a complete loss of hormone-induced RARa mRNA, whereas in cells transfected with pRARa (K79/K49), iSp3 did not affect E 2 -induced transactivation. This suggests that other GC-rich sites in the RARa promoter are required for ERa/Sp-mediated expression of this gene. Previous studies demonstrate that both Sp1 and Sp3 interact with ERa (Porter et al. 1996 , Saville et al. 2000 , Stoner et al. 2000 and we now show that both Sp1 and Sp4 colocalize with ERa in MCF-7 cells (Fig. 6) . Thus, at least for the RARa, CAD, and E 2 F1 genes, all three Sp proteins play a role in ERa/Sp-induced transactivation and, for E 2 F1, we also showed decreased protein expression (Fig. 3) .
The ChIP assay has been used extensively to investigate the ligand-induced assembly of ERa and other coactivators and nuclear cofactors on hormone-responsive gene promoters, and pS2 has been used extensively as a model for these studies (Shao et al. 2002 , Metivier et al. 2003 , Acevedo et al. 2004 , Krieg et al. 2004 , Sun et al. 2005 . This gene has a well-characterized E 2 -responsive non-consensus ERE motif, and several studies have reported that treatment of MCF-7 cells with E 2 recruits ERa to the pS2 promoter. Similar results were observed in this study (Fig. 7A) . Moreover, Sp1, Sp3, and Sp4 were also bound to the pS2 promoter, and PCR bands associated with the Sp protein-promoter interactions were not appreciably changed after treatment with E 2 . Sun et al. (2005) ) also reported interactions of Sp1 and Sp3 with the pS2 promoter. Band intensities associated with Sp3-promoter interactions were unchanged after treatment with E 2 , whereas Sp1-promoter interactions were decreased; however, these changes were not observed in this study.
We further investigated Sp protein interactions with the E 2 -responsive GC-rich regions of the E 2 F1, CAD, and RARa promoters in a ChIP assay and observed interactions of Sp1, Sp3, and Sp4 with these promoters in untreated MCF-7 cells ( Fig. 7B and D) . After treatment of MCF-7 cells with E 2 , Sp protein-promoter interactions did not appreciably change, and this was similar to that observed for interactions of Sp proteins with the pS2 promoter ( Fig. 7A) . Binding of Sp1, Sp3, and Sp4 to the CAD, E 2 F1, and RARa promoters was similar in solvent and E 2 -treated cells, and this is consistent with the role of all three proteins in mediating basal expression and hormonal activation of ERa/Sp-dependent CAD, E 2 F1, and RARa mRNAs (Figs 3C, 4C, and 5C ).
ERa was also constitutively bound to the GC-rich promoters and, in contrast to observations with the pS2 promoter ( Fig. 7A ; Shao et al. 2002 , Metivier et al. 2003 , Acevedo et al. 2004 , Krieg et al. 2004 , Sun et al. 2005 ), E 2 did not enhance ERa interactions with the CAD, E 2 F1, and RARa promoters in MCF-7 cells. Similar results were reported for the VEGFR2 promoter in ZR-75 cells (Higgins et al. 2006a) suggesting that there are fundamental differences in hormone-dependent interactions of ERa with E 2 -responsive promoters containing GC-rich or ERE motifs. We have carried out ChIP assays on several GC-rich promoters under a variety of conditions but invariably find that ERa, Sp1, Sp3, and Sp4 are associated with these promoters in the presence or absence of E 2 . These results suggest that there may also be differences in the recruitment of other nuclear cofactors to these gene promoters, and promoterdependent differences in coactivator recruitment are currently being investigated.
In summary, results of this study demonstrate that Sp1, Sp3, and Sp4 transcription factors are important for hormone-induced E 2 F1, CAD, and RARa mRNA expression. This is the first report showing the different contributions of ERa/Sp1, ERa/Sp3, and ERa/Sp4 on hormone-induced transactivation in MCF-7 cells. The relative effects of these individual proteins on ERa/Spmediated transactivation were dependent on the specific gene and gene promoter. Basal activity of the GC-rich proximal promoter regions of the E 2 F1, CAD, and RARa were differentially effected by Sp protein knockdown (Figs 3A, 4A, and 5A) and activity in cells transfected with pRARa-2 was only minimal decreased by iSps. Despite these differences, results of ChIP assays show that Sp1, Sp3, Sp4, and ERa were associated with all three promoters in the absence or presence of E 2 (Fig. 7) . In ongoing studies, we are further analyzing interactions of ERa and Sp proteins with the E 2 F1, RARa, CAD, and other gene promoters and comparing their binding to E 2 -responsive and non-responsive promoter sequences. We are also investigating the effects of ligand structure, coactivators, and cell context on this important genomic pathway of estrogen action using both cell culture and in vivo models.
